Searchable abstracts of presentations at key conferences in endocrinology

ea0012p119 | Steroids to include Cushing's | SFE2006

Determination of xenobiotic glucocorticoids by gas chromatography–mass spectrometry for clinical purposes

Walker CJ , Cowan DA , Taylor NF , Kicman AT

Methyl oxime–trimethylsilyl (MO-TMS) derivatisation with gas chromatography–mass spectrometric (GC-MS) analysis has been well established in the analysis of glucocorticoids and is still used in many laboratories for profiling endogenous steroids for clinical purposes. There appears to be a clinical need to extend the analysis to xenobiotic glucocorticoids, primarily to elucidate cases of patients presenting with adverse symptoms associated with glucocorticoid excess,...

ea0015p103 | Clinical practice/governance and case reports | SFEBES2008

11 Beta-hydroxysteroid dehydrogenase 2 activity in septic shock before and during treatment with hydrocortisone

Lloyd LA , Wayte A , Griffiths K , Thorpe CM , Taylor NF , Wilton A

Hydrocortisone treatment in septic shock promotes shock reversal and reduces mortality. We hypothesised the doses that used (200–300 mg/2 h) would result in plasma cortisol levels sufficient to saturate the 11 beta-hydroxysteroid dehydrogenase 2 enzyme (11 beta-HSD 2) with cortisol inactivation overload. Consequently cortisol would access the mineralocorticoid receptor producing mineralocorticoid effects. Hypertensive metabolic alkalotic effects would tend to counteract t...